Notice: Undefined index: email_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 31

Notice: Undefined index: friend_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 98

Notice: Undefined index: call_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 164

Notice: Undefined index: reecord_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 248

Notice: Undefined index: reecure_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 376

Notice: Undefined index: apply_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 455

Notice: Undefined index: getStem_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 617

Notice: Undefined index: consult_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 717

Notice: Undefined index: newsletter in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 805

Notice: Undefined index: lead_submit in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 818

Notice: Undefined index: lead_submit2 in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 849

Notice: Undefined index: lead_submit3 in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 878

Notice: Undefined index: lead_submit4 in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/common/cta.php on line 907

FAQs

Frequently Asked Questions

Everything you need to know about Stem Cell therapy. Expand All

  1. What are stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 7
    style="display:none" class="answers">Stem Cells are young, primitive and unspecialized cells with a remarkable potential to renew, differentiate and develop into any desired tissue or organ of the body. They retain the ability to self-renew and differentiate into a variety of different tissues. Recent research shows that stem cells are not restricted to one lineage, but can differentiate along different lineages. This means hematopoietic (blood forming) stem cells may form heart tissue or lung tissue when subjected to suitable conditions. Further stem cells have the unique ability to integrate with the parent tissue, thus opening up a plethora of applications of stem cells in treatment of various disorders.
  2. What are the sources of stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 10
    style="display:none" class="answers">There are various sources of stem cells. The prominent ones are:
    1. Embryonic stem cells from aborted fetuses: These cells are supposedly the most primitive and potentially the best source of stem cells for treatment of various disorders. They are derived from embryos and to be precise blastocysts as their inner cell mass. There are numerous ethical issues related to use of embryonic stem cells. The primitive nature of these cells has resulted in speculations that it can cause large number of unwanted side effects including juvenile malignancies if indiscriminately used.
    2. Umbilical stem cells from umbilical cord blood at birth: Umbilical cord blood stem cells are derived from the umbilical cord during childbirth. Once the baby is born the umbilical cord is clamped and the child is separated from the mother, after which the blood from the umbilical vessel is collected in a specialized blood bag.

      Umbilical cord blood is a readily available source of stem cells for treatments of routinely encountered disorders and is now used with increasing frequency as an alternative to bone marrow or peripheral stem cells for transplantation.

    3. Adult stem cells
      • Bone marrow:

        Stem cells derived from bone marrow had been the most widely practiced form of transplants till the advent of the cord blood derived stem cells.

        They can be obtained by a procedure called as bone marrow puncture from iliac crest of the hip bone. The procedure is painful and invasive as compared to umbilical cord blood collection.

      • Peripheral Blood:

        The stem cells in this case are collected by a procedure called “apheresis”. It requires the aid of a well programmed cell separator that would provide the desired stem cells from the blood stream. This procedure is generally utilized for autologous (for self) use only.

        The limitation of this procedure is that it is lengthy, the total cell yield is suspect and the procured stem cells are obviously less plastic, thus making the homing and engraftment a big problem in most cases.

      • Adult tissues: Stem cells can also be extracted from tissues like skin, cornea, fat, teeth, small intestine, and liver. These stem cells would also be generally utilized for autologous (for self) use.
  3. In what way are the umbilical cord blood stem cells different from the umbilical cord stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 31
    style="display:none" class="answers">

    The umbilical cord blood stem cells carry predominantly hematopoietic stem cells (HSCs). These cells are unspecialized and Blood Forming by nature. They generally give rise to blood forming cells like Red blood cells (RBCs), White Blood Cells (RBCs), Platelets etc. Recent research shows that in suitable conditions they have the ability to change their lineage i.e. though they are blood forming they can give rise to variety of tissues. This means hematopoietic (blood forming) stem cells may form heart tissue or lung tissue when subjected to suitable conditions, thus opening up a plethora of applications of stem cells in treatment of various disorders.

    Umbilical cord lining contains a jelly like substance supporting the umbilical vein & arteries. This is called Wharton’s jelly. It is an extremely rich source of Mesenchymal Stem Cells (MSCs). These Mesenchymal stem cells possess an extensive proliferative potential and ability to differentiate into various cell types. Thus, they play pivotal roles in the formation of nerves, muscles, fat, blood vessels, bones, cartilage and various vital organs of the body. This explains the wide scope of mesenchymal stem cells in various degenerative disorders.

  4. How are umbilical cord stem cells different from bone marrow stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 34
    style="display:none" class="answers">Umbilical cord blood stem cells carry a distinct & significant advantage over bone marrow stem cells for the following reasons:
    1. Umbilical cord blood stem cells are easy to collect, non invasive and painless as compared to bones marrow stem cells.
    2. Umbilical cord blood stem cells are younger and undifferentiated as compared to bone marrow stem cells; hence there is a higher rate of engraftment.
    3. Umbilical cord blood stem cells when used for transplant result in lower rate of GvHD (graft-vs-host disease) which is one of the major causes of transplant failure.
    4. Umbilical cord blood stem cells are rarely contaminated with latent viruses and hence considered non-infectious.
    5. Umbilical cord stem cells are young, naïve, primitive and unexposed to any disorders as opposed to bone marrow stem cells that would have withstood various diseases during the lifespan of the individual.
    6. Almost 70% of patients needing a bone marrow transplant are unable to find a donor using donor registries. This problem does not arise in umbilical cord blood transplant since recent reports of unmatched cord blood being used for transplantation has shown success.
  5. What is HLA-matching?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 46
    style="display:none" class="answers">

    HLA-matching is the criteria used to determine the compatibility between the recipient and the donor. It refers to six proteins present that appear on the surface of white blood cells and other tissues in the body. A transplant can only be performed if at least 3 of the 6 proteins match.

    When two people share the same Human Leukocyte Antigens (HLA), they are said to be a “match”, i.e. their tissues are immunologically compatible with each other. There is a basic rule in HLA inheritance. The rule mentions that there is a 25% possibility of an identical match amongst siblings.

  6. What is Graft-versus-Host-disease?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 49
    style="display:none" class="answers">

    Graft-versus-host disease (GvHD) is a common complication any stem cell transplant. In case of bone marrow transplantation the immune cells from the transplanted marrow recognize the recipient as “foreign” and mount an immunological attack. In effect the body rejects the transplanted stem cells. Cord blood transplants have a reduced incidence of GvHD because the immune cells within the cord blood are less reactive as compared to stem cells derived from other sources. By using your own stem cells there is no chance of GvHD.

    Graft-versus-host-disease (GvHD) is characterized by selective damage to the liver, skin and mucosa, and the gastrointestinal tract. In acute cases it can also cause death.

  7. What is the meaning of viability and potency of stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 52
    style="display:none" class="answers">

    “Viability” means “being alive” hence points to the ability of stem cells to withstand processing and storage. The quantum or success of viability is determined by measuring the number of “living” stem cells after processing. The concept of “viability” also assumes tremendous significance at the time of retrieval of stem cells, post the thawing process. Hence the importance of viability works as an indirect testimony of the quality of processing and storage of stem cells, a pedigree that Ree is proud of.

    Potency by definition means the strength or power of stem cells to successfully assume roles that are assigned to them. Being an assessment of the caliber of the processing facility, Ree with this careful, concerted approach towards isolation, processing and storage of stem cells is committed to accomplish the all important parameters required for successful transplants and hence guarantee maximum potency of stem cells. The extent of potency is determined by:

    1. Capacity of the procured stem cells for extensive proliferation and multiplication.
    2. Differentiation into desired cell type or tissue.
    3. Integrate into surrounding tissue after transplant.
    4. Function well for approximately the duration of the recipient’s life.
    5. Avoid harming the recipient in any way.
  8. How does early processing help improve the quality of stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 63
    style="display:none" class="answers">The cardinal rule in case of stem cell processing all over the globe remains the same. It says “Earlier the processing, greater is the final yield and quality of stem cells”. After thorough validation, it is now conclusively proven that the quality of stem cells rapidly and progressively diminishes with each passing hour after the first six hours of collection. Hence Ree has relentlessly pursued to ensure receipt of the sample in the central processing facility within six hours of collection. This inevitably ensures extraction of the finest caliber of stem cells with respect to the yield, quantity, viability, potency and sterility.
  9. What is stem cell banking?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 66
    style="display:none" class="answers">“Cord Blood Banking is a misnomer.” The relevant term should be stem cell banking. The reason for this is that the cord blood (or any other source of stem cells) is essentially processed after collection; and stem cells that are isolated are stored or “banked”, under cryogenic conditions with the help of an adequate liquid nitrogen backup system. Most cord blood banks store the stem cells for twenty one years after processing. However research has given ample evidence in suggesting that stem cells can be stored beyond twenty one years, even indefinitely provided they are processed and stored under appropriate storage conditions.
  10. How long can the stem cells be preserved?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 69
    style="display:none" class="answers">The stem cells are currently preserved for a period of 21 years. The contract is renewable after the said period. This practice is followed all over the globe; provided the cells are stored in cryogenic conditions with full-proof liquid nitrogen back up systems. Researchers are now investigating the possibility of storing stem cells for longer periods, possibly indefinitely under optimum storage conditions. However, the validation of the process can only occur once the period of storage exceeds 21 years. The oldest cord blood bank is approximately only 12 years old.
  11. What happens to the stem cells if I do not require them during the 20 year storage period?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 72
    style="display:none" class="answers">Stem cells are essentially stored for a period of 21 years by most cord blood banks. The advent of exhaustive research indicates that there is a fair possibility of requiring stem cells if you do bank them. Even if u haven’t banked stem cells there is a strong possibility of requiring stem cell therapy at some stage in life, especially in degenerative disorders. However incase, for whatever reason your banked stem cells are not retrieved in the 20 year storage period, the option of extending the tenure is provided at a prescribed fee prevailing at that time. At this stage, the ownership of stem cells shall be legally transferred to the child.
  12. What is the possibility of requiring stem cells if I bank them?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 75
    style="display:none" class="answers">With the advent of exhaustive research in the field of stem cell medicine, there is an ample possibility of requiring the banked stem cells. At this moment, there is established application of stem cells in numerous bone marrow (leukemia, thallasemia, sickle cell disease etc.), metabolic and storage disorders (Gaucher’s disease, Neuman Pick’s disease etc). However, dispute tall claims by most cord blood banks, admittedly there is at best a mild possibility of the child or his family suffering from these disorders and requiring stem cells for the purpose. However, recent research has shown promise with notable stem cell applications in host of chronic, degenerative, malignant disorders and “numerous no hope diseases” viz. Diabetes, Chronic Lung Disease, Osteoarthritis, Spinal Cord Injuries, Stroke, Parkinson’s Disease, Alzheimer’s disease, ALS, Multiple sclerosis, Dystrophies, Non-Healing Fractures of bone, Liver Cirrhosis and many more and with passage of time their role is bound to be more and more pronounced if not indispensible. Ree with help of ReeCure, shall also assist you in creating liaisons with suitable transplant physicians and hospitals to facilitate therapy this professionally.
  13. Is stem cell banking expensive?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 78
    style="display:none" class="answers">No. Stem cell banking is not expensive at all. Further, multiple payment options are available to reduce any concerns of affordability. Compared to the peace of mind that Stem Cell banking provides, the cost is negligible.
  14. How do you measure the quality of stem cells?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 81
    style="display:none" class="answers">After the processing and before cry-opreservation part of the sample is tested for:
    1. Mononuclear (MNC) count
    2. Absolute CD34+ count
    3. Mesenchymal Cell Count
    4. Stem cell Cell viability

    These studies are carried out on an in house Flow Cytometer which gives accurate results.

    A preservation certificate or Certificate of analysis which mentions all the results is sent to the mother within 15 to 20 days of processing the sample.

  15. Where and how are the stem cells stored?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 93
    style="display:none" class="answers">

    The samples of stem cells bear barcoded cryolabels which include an identifier code, mother's name, date of storage and assigned inventory number. The accompanying software aids in tracking of samples during retrieval.

    The stem cells are stored in vacuum insulated Liquid Nitrogen containers filled with ample amount of liquid Nitrogen specifically designed to withstand cryogenic conditions for long durations. The storage can be in 5 ml vials or multi-compartmentalized cryobags.

    The cry-opreservation is strictly maintained at controlled temperatures using liquid nitrogen (-196 deg℃) or its vapour (-175 deg ℃)

    Ree have employed the universally prevalent and AABB approved vapor phase as the desired mode for storage of samples.

    The liquid nitrogen levels are monitored with the help of requisite alarm systems and daily temperatures are carefully recorded using computerized data loggers. The tanks are replenished at regular intervals and are also equipped with inherent liquid nitrogen back up systems.

  16. Why should I trust Ree?
    Notice: Undefined index: a in /home/exlfe6jbr3kz/domains/reelabs.paperplane.net/html/includes/faqs/stem-cells.php on line 102
    style="display:none" class="answers">The strength of any organization is determined by quality of the facility and caliber of the workforce, both aspects that Ree are extremely proud of. Ree has set up its state of the art cord & cord blood processing lab with the latest and most sophisticated technology in the heart of Mumbai. The laboratory is manned by a well qualified, highly competent and skilled staff 24 hours a day, 7 days a week to receive and process cord blood specimens. Secondly, one look at the list of founders, promoters and directors of the company is adequate to instill confidence into the consumer. The promoters collectively have a remarkable track record in pharmaceuticals, FMCG, Pathology, Blood banking and clinical research, fields that have a close relation to the field of stem blood banking, research and therapy. The company is debt free with no encumbrances. Also Ree, unlike its competitors has endeavored to comprehensively encompass all aspects of this fascinating field including both stem cell banking (through ReeCord) and treatment (through ReeCure). Further, Ree with the able assistance of an outstanding panel of doctors, scientists and researchers is committed to carry the baton of stem cell research and therapy forward.
  1. What are stem cells?
    Stem Cells are young, primitive and unspecialized cells with a remarkable potential to renew, differentiate and develop into any desired tissue or organ of the body. They retain the ability to self-renew and differentiate into a variety of different tissues. Recent research shows that stem cells are not restricted to one lineage, but can differentiate along different lineages. This means hematopoetic (blood forming) stem cells may form heart tissue or lung tissue when subjected to suitable conditions. Further stem cells have the unique ability to integrate with the parent tissue, thus opening up a plethora of applications of stem cells in treatment of various disorders.
  2. What are the sources of stem cells?
    There are various sources of stem cells. The prominent ones are:
    1. Embryonic stem cells from aborted foetuses: These cells are supposedly the most primitive and potentially the best source of stem cells for treatment of various disorders. They are derived from embryos and to be precise blastocysts as their inner cell mass. There are numerous ethical issues related to use of embryonic stem cells. The primitive nature of these cells has resulted in speculations that it can cause large number of unwanted side effects including juvenile malignancies if indiscriminately used.
    2. Umbilical stem cells from umbilical cord blood at birth: Umbilical cord blood stem cells are derived from the umbilical cord during childbirth. Once the baby is born the umbilical cord is clamped and the child is separated from the mother, after which the blood from the umbilical vessel is collected in a specialized blood bag.

      Umbilical cord blood is a readily available source of stem cells for treatments of routinely encountered disorders and is now used with increasing frequency as an alternative to bone marrow or peripheral stem cells for transplantation.

    3. Adult stem cells
      • Bone marrow:

        Stem cells derived from bone marrow had been the most widely practiced form of transplants till the advent of the cord blood derived stem cells.

        They can be obtained by a procedure called as bone marrow puncture from iliac crest of the hip bone. The procedure is painful and invasive as compared to umbilical cord blood collection.

      • Peripheral Blood:

        The stem cells in this case are collected by a procedure called “apheresis”. It requires the aid of a well programmed cell separator that would provide the desired stem cells from the blood stream. This procedure is generally utilized for autolgous (for self) use only.

        The limitation of this procedure is that it is lengthy, the total cell yield is suspect and the procured stem cells are obviously less plastic, thus making the homing and engraftment a big problem in most cases.

      • Adult tissues: Stem cells can also be extracted from tissues like skin, cornea, fat, teeth, small intestine, and liver. These stem cells would also be generally utilized for autologous (for self) use.
  3. In what way are the umbilical cord blood stem cells different from the umbilical cord stem cells?

    The umbilical cord blood stem cells carry predominantly Hematopoetic stem cells (HSCs). These cells are unspecialized and Blood Forming by nature. They generally give rise to blood forming cells like Red blood cells (RBCs), White Blood Cells (RBCs), Platelets etc. Recent research shows that in suitable conditions they have the ability to change their lineage i.e. though they are blood forming they can give rise to variety of tissues. This means hematopoetic (blood forming) stem cells may form heart tissue or lung tissue when subjected to suitable conditions, thus opening up a plethora of applications of stem cells in treatment of various disorders.

    Umbilical cord lining contains a jelly like substance supporting the umbilical vein & arteries. This is called Wharton’s jelly. It is an extremely rich source of Mesenchymal Stem Cells (MSCs). These Mesenchymal stem cells possess an extensive proliferative potential and ability to differentiate into various cell types. Thus, they play pivotal roles in the formation of nerves, muscles, fat, blood vessels, bones, cartilage and various vital organs of the body. This explains the wide scope of mesenchymal stem cells in various degenerative disorders.

  4. How are umbilical cord stem cells different from bone marrow stem cells?
    Umbilical cord blood stem cells carry a distinct & significant advantage over bone marrow stem cells for the following reasons:
    1. Umbilical cord blood stem cells are easy to collect, non invasive and painless as compared to bones marrow stem cells.
    2. Umbilical cord blood stem cells are younger and undifferentiated as compared to bone marrow stem cells; hence there is a higher rate of engraftment.
    3. Umbilical cord blood stem cells when used for transplant result in lower rate of GvHD (graft vs host disease) which is one of the major causes of transplant failure.
    4. Umbilical cord blood stem cells are rarely contaminated with latent viruses and hence considered non infectious.
    5. Umbilical cord stem cells are young, naïve, primitive and unexposed to any disorders as opposed to bone marrow stem cells that would have withstood various diseases during the lifespan of the individual.
    6. Almost 70% of patients needing a bone marrow transplant are unable to find a donor using donor registries. This problem does not arise in umbilical cord blood transplant since recent reports of unmatched cord blood being used for transplantation has shown success.
  5. What is HLA matching?

    HLA matching is the criteria used to determine the compatibility between the recipient and the donor. It refers to six proteins present that appear on the surface of white blood cells and other tissues in the body. A transplant can only be performed if at least 3 of the 6 proteins match.

    When two people share the same Human Leukocyte Antigens (abbreviated as HLA), they are said to be a “match”, i.e. their tissues are immunologically compatible with each other. There is a basic rule in HLA inheritance. The rule mentions that there is a 25% possibility of an identical match amongst siblings.

  6. What is Graft-versus-Host-disease?

    Graft-versus-host disease (GvHD) is a common complication any stem cell transplant. In case of bone marrow transplantation the immune cells from the transplanted marrow recognize the recipient as “foreign” and mount an immunological attack. In effect the body rejects the transplanted stem cells. Cord blood transplants have a reduced incidence of GvHD because the immune cells within the cord blood are less reactive as compared to stem cells derived from other sources. By using your own stem cells there is no chance of GvHD.

    Graft-versus-host-disease (GvHD) is characterized by selective damage to the liver, skin and mucosa, and the gastrointestinal tract. In acute cases it can also cause death.

  7. What is the meaning of viability and potency of stem cells?

    “Viability” means “being alive” hence points to the ability of stem cells to withstand processing and storage. The quantum or success of viability is determined by measuring the number of “living” stem cells after processing. The concept of “viability” also assumes tremendous significance at the time of retrieval of stem cells, post the thawing process. Hence the importance of viability works as an indirect testimony of the quality of processing and storage of stem cells, a pedigree that Ree is proud of.

    Potency by definition means the strength or power of stem cells to successfully assume roles that are assigned to them. Being an assessment of the caliber of the processing facility, Ree with this careful, concerted approach towards isolation, processing and storage of stem cells is committed to accomplish the all important parameters required for successful transplants and hence guarantee maximum potency of stem cells. The extent of potency is determined by:

    1. Capacity of the procured stem cells for extensive proliferation and multiplication.
    2. Differentiation into desired cell type or tissue.
    3. Integrate into surrounding tissue after transplant.
    4. Function well for approximately the duration of the recipient’s life.
    5. Avoid harming the recipient in any way.
  8. How does early processing help improve the quality of stem cells?
    The cardinal rule in case of stem cell processing all over the globe remains the same. It says “Earlier the processing, greater is the final yield and quality of stem cells”. After thorough validation, it is now conclusively proven that the quality of stem cells rapidly and progressively diminishes with each passing hour after the first six hours of collection. Hence Ree has relentlessly pursued to ensure receipt of the sample in the central processing facility within six hours of collection. This inevitably ensures extraction of the finest caliber of stem cells with respect to the yield, quantity, viability, potency and sterility.
  9. What is stem cell banking?
    “Cord Blood Banking is a misnomer.” The relevant term should be stem cell banking. The reason for this is that the cord blood (or any other source of stem cells) is essentially processed after collection; and stem cells that are isolated are stored or “banked”, under cryogenic conditions with the help of an adequate liquid nitrogen backup system. Most cord blood banks store the stem cells for twenty one years after processing. However research has given ample evidence in suggesting that stem cells can be stored beyond twenty one years, even indefinitely provided they are processed and stored under appropriate storage conditions.
  10. How long can the stem cells be preserved?
    The stem cells are currently preserved for a period of 21 years. The contract is renewable after the said period. This practice is followed all over the globe; provided the cells are stored in cryogenic conditions with full-proof liquid nitrogen back up systems. Researchers are now investigating the possibility of storing stem cells for longer periods, possibly indefinitely under optimum storage conditions. However, the validation of the process can only occur once the period of storage exceeds 21 years. The oldest cord blood bank is approximately only 12 years old.
  11. What happens to the stem cells if I do not require them during the 20 year storage period?
    Stem cells are essentially stored for a period of 21 years by most cord blood banks. The advent of exhaustive research indicates that there is a fair possibility of requiring stem cells if you do bank them. Even if u haven’t banked stem cells there is a strong possibility of requiring stem cell therapy at some stage in life, especially in degenerative disorders. However incase, for whatever reason your banked stem cells are not retrieved in the 20 year storage period, the option of extending the tenure is provided at a prescribed fee prevailing at that time. At this stage, the ownership of stem cells shall be legally transferred to the child.
  12. What is the possibility of requiring stem cells if I bank them?
    With the advent of exhaustive research in the field of stem cell medicine, there is an ample possibility of requiring the banked stem cells. At this moment, there is established application of stem cells in numerous bone marrow (leukemia, thallasemia, sickle cell disease etc.), metabollic and storage disorders (Gaucher’s disease, Neuman Pick’s disease etc). However, dispute tall claims by most cord blood banks, admittedly there is at best a mild possibility of the child or his family suffering from these disorders and requiring stem cells for the purpose. However, recent research has shown promise with notable stem cell applications in host of chronic, degenerative, malignant disorders and “numerous no hope diseases” viz. Diabetes, Chronic Lung Disease, Osteo-arthritis, Spinal Cord Injuries, Stroke, Parkinson’s Disease, Alzheimer’s disease, ALS, Multiple sclerosis, Dystrophies, Non-Healing Fractures of bone, Liver Cirrhosis and many more and with passage of time their role is bound to be more and more pronounced if not indispensible.Ree with help of ReeCure, shall shall also assist you in creating liaisons with suitable transplant physicians and hospitals to facilitate therapy this professionally.
  13. Is stem cell banking expensive?
    No. Stem cell banking is not expensive at all. Further, multiple payment options are available to reduce any concerns of affordability. Compared to the peace of mind that Stem Cell banking provides, the cost is negligible.
  14. How do you measure the quality of stem cells?
    After the processing and before cryopreservation part of the sample is tested for:
    1. Mononuclear (MNC) count
    2. Absolute CD34+ count
    3. Mesenchymal Cell Count
    4. Stem cell Cell viability

    These studies are carried out on an in house Flow Cytometer which gives accurate results.

    A preservation certificate or Certificate of analysis which mentions all the results is sent to the mother within 15 to 20 days of processing the sample.

  15. Where and how are the stem cells stored?

    The samples of stem cells bear barcoded cryolabels which include an identifier code, mother's name, date of storage and assigned inventory number. The accompanying software aids in tracking of samples during retrieval.

    The stem cells are stored in vacuum insulated Liquid Nitrogen containers filled with ample amount of liquid Nitrogen specifically designed to withstand cryogenic conditions for long durations. The storage can be in 5 ml vials or multi-compartmentalized cryobags.

    The cryopreservation is strictly maintained at controlled temperatures using liquid nitrogen (-196 deg Celsius) or its vapour (-175 deg Celsius)

    Ree have employed the universally prevalent and AABB approved vapour phase as the desired mode for storage of samples.

    The liquid nitrogen levels are monitored with the help of requisite alarm systems and daily temperatures are carefully recorded using computerized data loggers. The tanks are replenished at regular intervals and are also equipped with inherent liquid nitrogen back up systems.

  16. Why should I trust Ree ?
    The strength of any organization is determined by quality of the facility and caliber of the workforce, both aspects that Ree are extremely proud of. Ree has set up its state of the art cord & cord blood processing lab with the latest and most sophisticated technology in the heart of Mumbai. The laboratory is manned by a well qualified, highly competent and skilled staff 24 hours a day, 7 days a week to receive and process cord blood specimens. Secondly, one look at the list of founders, promoters and directors of the company is adequate to instill confidence into the consumer. The promoters collectively have a remarkable track record in pharmaceuticals, FMCG, Pathology, Blood banking and clinical research, fields that have a close relation to the field of stem blood banking, research and therapy. The company is debt free with no encumbrances. Also Ree, unlike its competitors has endeavored to comprehensively encompass all aspects of this fascinating field including both stem cell banking (through ReeCord) and treatment (through ReeCure). Further, Ree with the able assistance of an outstanding panel of doctors, scientists and researchers is committed to carry the baton of stem cell research and therapy forward.
  • Click to email to a friend
  • Print this page
  • Bookmark this page

Enrol Nowfor ReeCord Banking

Enrol Nowfor Stem Cell Therapy